Corvia Medical

About:

Corvia Medical develops transcatheter device designed to reduce the symptoms or slow the progression of heart failure.

Website: https://corviamedical.com/home/

Top Investors: General Catalyst, Accelmed, Third Rock Ventures, Lumira Ventures

Description:

Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009 and headquartered in Andover, Massachusetts.

Total Funding Amount:

$119M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Andover, Massachusetts, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)corviamedical.com

Founders:

David Celermajer

Number of Employees:

11-50

Last Funding Date:

2022-06-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai